Sponsor
Sermonix Pharmaceuticals Inc.
250 East Broad Street Suite 250, 43215-3778, United States
About the sponsor
Sermonix Pharmaceuticals Inc. focuses on clinical research in locally advanced breast cancer and metastatic breast cancer, with attention to estrogen receptor positive (ER+) and human epidermal growth factor 2 negative (HER2-) disease.
- Advanced breast cancer
- ER+/HER2- breast cancer
- Locally advanced disease
- Metastatic disease
The sponsor’s research activity is centered on treatment options for women and men with advanced hormone receptor-driven breast cancer.
Try clearing a filter, or search the whole catalogue.
Are you running a clinical trial?
Increase visibility for your trials and help patients find your site through our platform.